Tariffs: Should Pharma and Biotech Manufacturers Relocate / Build Manufacturing in the U.S.?
As U.S. trade policy tightens, pharmaceutical and biotech companies face a pivotal strategic question: does
As U.S. trade policy tightens, pharmaceutical and biotech companies face a pivotal strategic question: does
Germany: Europe’s Largest Pharma Market Germany is one of the key focus markets for pharma,
In an effort to combat the high prices for prescription drugs in the U.S., the
Many biotech executives we currently meet report difficulties in securing their next financing round to
What is DiGA in short? DiGA, short for Digitale Gesundheitsanwendungen, translates to Digital Health Applications
The U.S. pharmaceutical landscape is set for another major shift. On May 12th, President Trump